Natus Medical
(NASDAQ) NTUS
Natus Medical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$478.30M
Net Income (TTM)
$12.69M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NTUS News
Is Natus Medical Stock a Buy?
Natus Medical Is All Grown Up
Natus Has Some Growing Up to Do
NTUS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Natus Medical
Industry
{'id': 40, 'name': 'Healthcare Equipment and Supplies'}
Employees
1,400
CEO
Thomas J. Sullivan, MBA
Website
www.natus.comHeadquarters
Pleasanton, CA 53562, US
NTUS Financials
Key Financial Metrics (TTM)
Gross Margin
58%
Operating Margin
4%
Net Income Margin
3%
Return on Equity
3%
Return on Capital
5%
Return on Assets
2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$273.68M
Operating Income
$21.23M
EBITDA
$49.32M
Operating Cash Flow
$63.99M
Capital Expenditure
$3.62M
Free Cash Flow
$60.38M
Cash & ST Invst.
$75.59M
Total Debt
$11.53M
Natus Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$119.79M
+4.2%
Gross Profit
$65.41M
-1.6%
Gross Margin
54.60%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1,400
N/A
Net Income
$1.90M
-20.6%
EBITDA
$10.31M
-5.3%
Quarterly Fundamentals
Net Cash
$74.05M
+148.2%
Accounts Receivable
$103.71M
+13.6%
Inventory
$72.24M
+4.0%
Long Term Debt
$5.75M
-29.7%
Short Term Debt
$4.48M
-89.5%
Return on Assets
2.34%
N/A
Return on Invested Capital
4.72%
N/A
Free Cash Flow
$7.83M
-67.3%
Operating Cash Flow
$8.90M
-64.0%